SFS
ANIX icon

Sowell Financial Services’s Anixa Biosciences ANIX Stock Holding History

Sowell Financial Services’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000
Closed -$3K – 2509
2020
Q2 		$3K Buy
+1,000
New +$2.07K ﹤0.01% 2021

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAS
Avantax Advisory Services Dallas, Texas $18.2B AUM 15.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Sowell Financial Services's ANIX Position: Q3 2020 in Review

Sowell Financial Services sold out of Anixa Biosciences (ANIX) in Q3 2020, closing a stake of 1,000 shares — an estimated $3K sold.

Sowell Financial Services first reported a position in ANIX in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 21 funds tracked by Wall St. Rank hold ANIX as of Q3 2020.

  • Sowell Financial Services reported no remaining Anixa Biosciences position as of Q3 2020 after selling out during the quarter.
  • Sowell Financial Services sold 1,000 Anixa Biosciences shares in Q3 2020, an estimated $3K.
  • Sowell Financial Services first reported a position in Anixa Biosciences in Q2 2020 and held it in 1 quarter.
  • Sowell Financial Services's Anixa Biosciences position peaked at $3K in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2020.

Based on Sowell Financial Services's 13F filing for Q3 2020, filed 12 Nov 2020.